PAR
Click for more information
1.92% 25.5¢ paradigm biopharmaceuticals limited..

Not sure if anyone has posted this, but in Blackrock's 2023...

  1. Zenox
    1,216 Posts.
    lightbulb Created with Sketch. 1375
    clock Created with Sketch.
    04/01/23
    11:58
    Post #: 65523986
    Not sure if anyone has posted this, but in Blackrock's 2023 investment outlook they appear to be bullish on companies like PAR that will benefit amid aging populations, which is ideal due to the increasingly changing nature of the markets. Not intended as investment advice, dyor.

    https://hotcopper.com.au/data/attachments/4943/4943330-aa58427f189cd26ad944f90ae8119cb9.jpg
    Last edited by Zenox: 04/01/23
    PAR Price at posting: $1.41 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢ 		Change
-0.005(1.92%) 		Mkt cap ! $92.69M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $259.8K 984.3K

Buyers (Bids)

No. Vol. Price($)
1 5140 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 7 1
View Market Depth
Last trade - 15.59pm 28/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.